These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
89 related articles for article (PubMed ID: 10397239)
21. Functional analysis of hMLH1 variants and HNPCC-related mutations using a human expression system. Trojan J; Zeuzem S; Randolph A; Hemmerle C; Brieger A; Raedle J; Plotz G; Jiricny J; Marra G Gastroenterology; 2002 Jan; 122(1):211-9. PubMed ID: 11781295 [TBL] [Abstract][Full Text] [Related]
22. Mismatch repair genes hMLH1 and hMSH2 and colorectal cancer: a HuGE review. Mitchell RJ; Farrington SM; Dunlop MG; Campbell H Am J Epidemiol; 2002 Nov; 156(10):885-902. PubMed ID: 12419761 [TBL] [Abstract][Full Text] [Related]
23. Association of a duodenal follicular lymphoma and hereditary nonpolyposis colorectal cancer. Rosty C; Brière J; Cellier C; Delabesse E; Carnot F; Barbier JP; Laurent-Puig P Mod Pathol; 2000 May; 13(5):586-90. PubMed ID: 10824932 [TBL] [Abstract][Full Text] [Related]
24. Expression of the hMLH1 and hMSH2 proteins in normal tissues: relationship to cancer predisposition in hereditary non-polyposis colon cancer. Plevová P; Sedláková E; Zapletalová J; Krepelová A; Skýpalová P; Kolár Z Virchows Arch; 2005 Feb; 446(2):112-9. PubMed ID: 15735976 [TBL] [Abstract][Full Text] [Related]
25. Clinical impact of molecular genetic diagnosis, genetic counseling, and management of hereditary cancer. Part II: Hereditary nonpolyposis colorectal carcinoma as a model. Lynch HT; Watson P; Shaw TG; Lynch JF; Harty AE; Franklin BA; Kapler CR; Tinley ST; Liu B; Lerman C Cancer; 1999 Dec; 86(11 Suppl):2457-63. PubMed ID: 10630171 [TBL] [Abstract][Full Text] [Related]
27. Tolerance of human MSH2+/- lymphoblastoid cells to the methylating agent temozolomide. Marra G; D'Atri S; Corti C; Bonmassar L; Cattaruzza MS; Schweizer P; Heinimann K; Bartosova Z; Nyström-Lahti M; Jiricny J Proc Natl Acad Sci U S A; 2001 Jun; 98(13):7164-9. PubMed ID: 11416201 [TBL] [Abstract][Full Text] [Related]
28. hMSH2 is the most commonly mutated MMR gene in a cohort of Greek HNPCC patients. Apessos A; Mihalatos M; Danielidis I; Kallimanis G; Agnantis NJ; Triantafillidis JK; Fountzilas G; Kosmidis PA; Razis E; Georgoulias VA; Nasioulas G Br J Cancer; 2005 Jan; 92(2):396-404. PubMed ID: 15655560 [TBL] [Abstract][Full Text] [Related]
29. Genomic DNA-based hMSH2 and hMLH1 mutation screening in 32 Eastern United States hereditary nonpolyposis colorectal cancer pedigrees. Weber TK; Conlon W; Petrelli NJ; Rodriguez-Bigas M; Keitz B; Pazik J; Farrell C; O'Malley L; Oshalim M; Abdo M; Anderson G; Stoler D; Yandell D Cancer Res; 1997 Sep; 57(17):3798-803. PubMed ID: 9288790 [TBL] [Abstract][Full Text] [Related]
30. CpG dinucleotides in the hMSH2 and hMLH1 genes are hotspots for HNPCC mutations. Maliaka YK; Chudina AP; Belev NF; Alday P; Bochkov NP; Buerstedde JM Hum Genet; 1996 Feb; 97(2):251-5. PubMed ID: 8566964 [TBL] [Abstract][Full Text] [Related]
31. Population carrier frequency of hMSH2 and hMLH1 mutations. Dunlop MG; Farrington SM; Nicholl I; Aaltonen L; Petersen G; Porteous M; Carothers A Br J Cancer; 2000 Dec; 83(12):1643-5. PubMed ID: 11104559 [TBL] [Abstract][Full Text] [Related]
32. Excess of hMLH1 germline mutations in Swiss families with hereditary non-polyposis colorectal cancer. Hutter P; Couturier A; Membrez V; Joris F; Sappino AP; Chappuis PO Int J Cancer; 1998 Dec; 78(6):680-4. PubMed ID: 9833759 [TBL] [Abstract][Full Text] [Related]
33. Two types of sporadic multiple colorectal cancers with and without HNPCC-like genetic instability. Komura K; Masuda H; Esumi M Hepatogastroenterology; 1999; 46(30):3115-20. PubMed ID: 10626171 [TBL] [Abstract][Full Text] [Related]
34. [Molecular diagnosis and clinical consequences in families with HNPCC syndrome]. Pistorius S; Plaschke J; Kruppa C; Rüschoff J; Nagel M; Saeger HD; Schackert HK Langenbecks Arch Chir Suppl Kongressbd; 1998; 115(Suppl I):293-7. PubMed ID: 14518263 [TBL] [Abstract][Full Text] [Related]
35. Risk of colorectal and endometrial cancer for carriers of mutations of the hMLH1 and hMSH2 gene: correction for ascertainment. Quehenberger F; Vasen HF; van Houwelingen HC J Med Genet; 2005 Jun; 42(6):491-6. PubMed ID: 15937084 [TBL] [Abstract][Full Text] [Related]
36. hMLH1 mutations in hereditary nonpolyposis colorectal cancer kindreds. Mutations in brief no. 182. Online. Panariello L; Scarano MI; de Rosa M; Capasso L; Renda A; Riegler G; Rossi GB; Salvatore F; Izzo P Hum Mutat; 1998; 12(3):216-7. PubMed ID: 10660333 [TBL] [Abstract][Full Text] [Related]
37. Molecular genetic evidence of the occurrence of breast cancer as an integral tumor in patients with the hereditary nonpolyposis colorectal carcinoma syndrome. Risinger JI; Barrett JC; Watson P; Lynch HT; Boyd J Cancer; 1996 May; 77(9):1836-43. PubMed ID: 8646682 [TBL] [Abstract][Full Text] [Related]
38. Apoptosis induced by overexpression of hMSH2 or hMLH1. Zhang H; Richards B; Wilson T; Lloyd M; Cranston A; Thorburn A; Fishel R; Meuth M Cancer Res; 1999 Jul; 59(13):3021-7. PubMed ID: 10397236 [TBL] [Abstract][Full Text] [Related]
39. Clinical findings with implications for genetic testing in families with clustering of colorectal cancer. Wijnen JT; Vasen HF; Khan PM; Zwinderman AH; van der Klift H; Mulder A; Tops C; Møller P; Fodde R N Engl J Med; 1998 Aug; 339(8):511-8. PubMed ID: 9709044 [TBL] [Abstract][Full Text] [Related]
40. Re: Characterization of hereditary nonpolyposis colorectal cancer families from a population-based series of cases. Evans DG; Wu CL; Walsh S; Hansen I; Verma L; Robinson C; Kingston R; Maher ER J Natl Cancer Inst; 2001 May; 93(9):716-7. PubMed ID: 11333295 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]